Flexion Therapeutics, Inc.
FLUTICASONE EXTENDED-RELEASE FORMULATIONS AND METHODS OF USE THEREOF

Last updated:

Abstract:

This disclosure relates to extended-release fluticasone propionate (FP) formulations that include small microparticles and/or nanoparticles and methods of using these extended-release FP formulations for treating pain and/or inflammation in a subject.

Status:
Application
Type:

Utility

Filling date:

16 Mar 2018

Issue date:

9 Jan 2020